Sibel Health Announces Close of New Series C Financing and New FDA 510(k) Clearance
CHICAGO, March 20, 2025 /PRNewswire/ — Sibel Health, an award-winning medical technology company, is pleased to announce the closing of $30 million in new equity financing and its 7th FDA 510(k) clearance. The equity financing was led by Sibel’s existing investors, the Steele Foundation for Hope and Dräger, to accelerate commercial deployment of the ANNE® One monitoring platform.
